Vesicular stomatitis virus: an exciting new therapeutic oncolytic virus candidate for cancer or just another chapter from Field's Virology? (Q35571358)

8 August 2017

1 reference

title

Vesicular stomatitis virus: an exciting new therapeutic oncolytic virus candidate for cancer or just another chapter from Field's Virology? (English)

1 reference

8 August 2017

0 references

1 reference

1 reference

Martin A Giedlin

1

1 reference

8 August 2017

David N Cook

series ordinal

2

1 reference

8 August 2017

Thomas W Dubensky

series ordinal

3

1 reference

8 August 2017

language of work or name

1 reference

1 October 2003

1 reference

8 August 2017

1 reference

8 August 2017

4

1 reference

8 August 2017

241-243

1 reference

8 August 2017

4

1 reference

Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

Different host-cell shutoff strategies related to the matrix protein lead to persistence of vesicular stomatitis virus mutants on fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

Innate recognition of bacteria by a macrophage cytosolic surveillance pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

RNA viruses as virotherapy agents

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

Novel approaches to cancer therapy using oncolytic viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900251-4

7 January 2021

10.1016/S1535-6108(03)00251-4

Identifiers

DOI

1 reference

8 August 2017

1 reference